OTCPK:MEPD.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Medipal Holdings Corporation engages in the pharmaceutical prescription wholesale business. More Details


Snowflake Analysis

Flawless balance sheet, good value and pays a dividend.

Share Price & News

How has MediPal Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MEPD.F has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

MEPD.F

1.3%

US Healthcare

1.3%

US Market


1 Year Return

n/a

MEPD.F

21.2%

US Healthcare

15.8%

US Market

Return vs Industry: Insufficient data to determine how MEPD.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how MEPD.F performed against the US Market.


Shareholder returns

MEPD.FIndustryMarket
7 Day0%1.3%1.3%
30 Day0%-4.3%-4.1%
90 Dayn/a-0.7%8.4%
1 Yearn/a22.8%21.2%18.4%15.8%
3 Yearn/a23.8%18.5%38.2%29.0%
5 Yearn/a50.2%39.6%84.9%64.0%

Price Volatility Vs. Market

How volatile is MediPal Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is MediPal Holdings undervalued compared to its fair value and its price relative to the market?

10.5%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: MEPD.F ($19.52) is trading below our estimate of fair value ($21.8)

Significantly Below Fair Value: MEPD.F is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: MEPD.F is good value based on its PE Ratio (12.4x) compared to the US Healthcare industry average (22.4x).

PE vs Market: MEPD.F is good value based on its PE Ratio (12.4x) compared to the US market (18.2x).


Price to Earnings Growth Ratio

PEG Ratio: MEPD.F is poor value based on its PEG Ratio (3.3x)


Price to Book Ratio

PB vs Industry: MEPD.F is good value based on its PB Ratio (0.9x) compared to the US Healthcare industry average (2.9x).


Next Steps

Future Growth

How is MediPal Holdings forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

3.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MEPD.F's forecast earnings growth (3.8% per year) is above the savings rate (2.2%).

Earnings vs Market: MEPD.F's earnings (3.8% per year) are forecast to grow slower than the US market (23.2% per year).

High Growth Earnings: MEPD.F's earnings are forecast to grow, but not significantly.

Revenue vs Market: MEPD.F's revenue (1.4% per year) is forecast to grow slower than the US market (9.7% per year).

High Growth Revenue: MEPD.F's revenue (1.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MEPD.F's Return on Equity is forecast to be low in 3 years time (6.4%).


Next Steps

Past Performance

How has MediPal Holdings performed over the past 5 years?

6.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MEPD.F has high quality earnings.

Growing Profit Margin: MEPD.F's current net profit margins (1.1%) are higher than last year (1.1%).


Past Earnings Growth Analysis

Earnings Trend: MEPD.F's earnings have grown by 6.1% per year over the past 5 years.

Accelerating Growth: MEPD.F's earnings growth over the past year (8.4%) exceeds its 5-year average (6.1% per year).

Earnings vs Industry: MEPD.F earnings growth over the past year (8.4%) underperformed the Healthcare industry 31.1%.


Return on Equity

High ROE: MEPD.F's Return on Equity (8.1%) is considered low.


Next Steps

Financial Health

How is MediPal Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: MEPD.F's short term assets (¥1,144.2B) exceed its short term liabilities (¥939.6B).

Long Term Liabilities: MEPD.F's short term assets (¥1,144.2B) exceed its long term liabilities (¥94.9B).


Debt to Equity History and Analysis

Debt Level: MEPD.F's debt to equity ratio (6.6%) is considered satisfactory.

Reducing Debt: MEPD.F's debt to equity ratio has reduced from 7.7% to 6.6% over the past 5 years.

Debt Coverage: MEPD.F's debt is well covered by operating cash flow (139%).

Interest Coverage: MEPD.F earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is MediPal Holdings's current dividend yield, its reliability and sustainability?

1.94%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: MEPD.F's dividend (1.94%) is higher than the bottom 25% of dividend payers in the US market (1.66%).

High Dividend: MEPD.F's dividend (1.94%) is low compared to the top 25% of dividend payers in the US market (4.7%).


Stability and Growth of Payments

Stable Dividend: MEPD.F's dividends per share have been stable in the past 10 years.

Growing Dividend: MEPD.F's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (23.6%), MEPD.F's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

8.0yrs

Average management tenure


CEO

Shuichi Watanabe (68 yo)

8.42yrs

Tenure

Mr. Shuichi Watanabe has been Chief Executive Officer and President at MediPal Holdings Corporation since April 2012. Mr. Watanabe served as the Chief Executive Officer and President of Mediceo Corporation ...


Leadership Team

NamePositionTenureCompensationOwnership
Shuichi Watanabe
CEO, President & Representative Director8.42yrsno data0.078%
¥ 3.4m
Yuji Sakon
MD, GM of Administration Division & Director8.67yrsno datano data
Yasuhiro Choufuku
VP & Director13.67yrsno data0.022%
¥ 973.5k
Hiroshi Yarimizu
Senior Managing Exec. Officer & Manager of Corporate Planning and PR Dept. - Administration Divisionno datano datano data
Masanori Kawahara
Managing Executive Officerno datano datano data
Toshihide Yoda
Senior MD10.67yrsno data0.0043%
¥ 186.6k
Shinjiro Watanabe
GM of Information Systems Management Division & Director7.67yrsno data0.012%
¥ 518.0k
Tomohiko Kimura
Senior Managing Exec. Officer & Deputy GM of Business Development Departmentno datano datano data
Hisashi Tsutsui
Executive Officer & Deputy GM of Administration Division no datano datano data
Mitsuhiro Kyohgoku
Executive Officer & Deputy GM of Administration Divisionno datano datano data
Tadashi Kashiwagi
Executive Officer & Deputy GM of Information Systems Management Divisionno datano datano data
Kazuo Hashida
Executive Officer and Manager of Finance & Accounting Department - Administration Divisionno datano datano data

8.0yrs

Average Tenure

Experienced Management: MEPD.F's management team is seasoned and experienced (8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Shuichi Watanabe
CEO, President & Representative Director8.42yrsno data0.078%
¥ 3.4m
Yuji Sakon
MD, GM of Administration Division & Director8.67yrsno datano data
Yasuhiro Choufuku
VP & Director13.67yrsno data0.022%
¥ 973.5k
Toshihide Yoda
Senior MD10.67yrsno data0.0043%
¥ 186.6k
Shinjiro Watanabe
GM of Information Systems Management Division & Director7.67yrsno data0.012%
¥ 518.0k
Takuro Hasegawa
Director16.67yrsno data0.065%
¥ 2.8m
Toshio Hirasawa
Full-Time Audit & Supervisory Board Memberno datano data0.012%
¥ 538.5k
Kuniko Shoji
Independent Outside Director2.67yrsno datano data
Toshio Asano
Independent Outside Director3.67yrsno data0.00095%
¥ 41.3k
Mitsuko Kagami
Independent Outside Director6.67yrsno datano data
Yoko Sanuki
Outside Audit & Supervisory Board Memberno datano data0.0024%
¥ 103.5k
Seiichi Kasutani
Director1.67yrsno datano data

8.2yrs

Average Tenure

68yo

Average Age

Experienced Board: MEPD.F's board of directors are considered experienced (8.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

MediPal Holdings Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: MediPal Holdings Corporation
  • Ticker: MEPD.F
  • Exchange: OTCPK
  • Founded: 1898
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: JP¥454.152b
  • Listing Market Cap: JP¥4.350b
  • Shares outstanding: 209.96m
  • Website: https://www.medipal.co.jp

Number of Employees


Location

  • MediPal Holdings Corporation
  • 2-7-15, Yaesu
  • Chuo-ku
  • Tokyo
  • 104-8461
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
7459TSE (The Tokyo Stock Exchange)YesCommon StockJPJPYSep 1995
MEPD.FOTCPK (Pink Sheets LLC)YesCommon StockUSUSDSep 1995
59ZDB (Deutsche Boerse AG)YesCommon StockDEEURSep 1995
MAHL.YOTCPK (Pink Sheets LLC)UNSPONSORED ADRUSUSDNov 2008

Biography

Medipal Holdings Corporation engages in the pharmaceutical prescription wholesale business. It also engages in delivering cosmetics, daily necessities, OTC pharmaceuticals, and other products; and animal h ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/20 08:01
End of Day Share Price2020/06/23 00:00
Earnings2020/06/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.